相关实验视频
Updated: Jul 19, 2025

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.1K
对于微生物学证实肺结核的成年患者的营养支持:在Jharkhand,印度的RATIONS试验中嵌入的编程队列中的结果
Anurag Bhargava1, Madhavi Bhargava2, Ajay Meher3
1Department of Medicine, Yenepoya Medical College, Mangalore, India; Center for Nutrition Studies, Yenepoya (Deemed to be University), Mangalore, India; Department of Medicine, McGill University, Montreal, QC, Canada.
The Lancet. Global health
|August 11, 2023
概括
营养支持显著降低了印度体重不足患者的结核病死亡率. 在这种高负担环境中,早期体重增加,特别是在两个月内,对于提高生存率和治疗成功至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 营养科学 营养科学
背景情况:
- 营养不良是结核病 (TB) 患者的重要伴随性疾病,特别是在印度等高负担国家.
- 在RATIONS试验中,研究了营养支持对家庭接触者结核病发病率的影响.
- 这项研究专门评估了营养支持对RATIONS试验队列患者结果的影响.
研究的目的:
- 评估营养支持对印度成年结核病患者结核病死亡率,治疗成功和其他临床结果的影响.
- 在接受营养支持的队列中确定结核病死亡率的预测因素.
- 评估体重增加与结核病死亡风险之间的关联.
主要方法:
- 一项基于现场的集群随机对照试验招募了2800名经微生物学证实肺结核的成年患者.
- 患者接受6-12个月的营养支持 (食物配给和微量营养素药片).
- 记录了包括治疗成功,死亡率,随访损失,体重增加,BMI和绩效状态的变化在内的结果. 使用Poisson和Cox回归分析了死亡率的预测因素.
主要成果:
- 超过82%的受试患者在基线时体重不足 (BMI <18.5 kg/m2).
- 在93.7%的患者中,治疗成功,3.9%的患者患有结核病的死亡率.
- 2个月后体重增加5%与死亡风险显著降低有关 (调整后HR为0.39). 低绩效状态和糖尿病是死亡率的预测因素.
结论:
- 营养支持对于改善营养不良结核病患者治疗结果至关重要.
- 早期和显著的体重增加,特别是在治疗的前两个月内,与减少结核病死亡率密切相关.
- 将营养支持整合到以患者为中心的护理中,对于在资源有限的环境中管理结核病至关重要.
相关概念视频
Pulmonary Tuberculosis IV
162
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
162
Pulmonary Tuberculosis V
201
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
201
Pulmonary Tuberculosis I
268
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
268
Pulmonary Tuberculosis II
263
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
263
Pulmonary Tuberculosis III
365
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
365
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355

